University of Vermont

Institutional Biosafety Committee - IBC

Human Gene Transfer

Human Gene Transfer


“Human Gene Transfer” or “HGT” is used to describe research involving the transfer of recombinant DNA, or DNA or RNA derived from recombinant DNA, into human subjects. It is also sometimes referred to as “Gene Therapy.” 

Effective April 27, 2016, UVM Institutional Biosafety Committee will determine whether investigator-initiated research requires RAC review based on specific criteria. If the project is sponsored, the sponsor is responsible for determining if RAC review is required.

Review and approval of a gene transfer protocol can be complex, therefore we have developed a step-by-step guide for submission of a human gene transfer protocol at UVM/UVMMC.


Human Gene Therapy Review Procedures

Other Resources:



More information to come.

Last modified September 08 2017 02:33 PM

Ethics and Compliance Reporting and Help Line
Contact UVM © 2017 The University of Vermont - Burlington, VT 05405 - (802) 656-3131